Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Taxotere and Topotecan for Recurrent Gynecologic Cancers
NCT00231855Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel and topotecan in ovarian cancer, primary peritoneal cancer (PPC), endometrial cancer (EC) and 1 more, sponsored by Montefiore Medical Center. Primary endpoint: Overall Clinical Response Rate. Started Nov 2004; status: completed.
02
Drugs
docetaxeltopotecan
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)endometrial cancer (EC)uterine cancer
Beyond the preview
Go deeper on NCT00231855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231855.